Novel endoscopic treatment strategy for early esophageal cancer in cirrhotic patients with esophageal varices

  • Authors:
    • Zheng‑Guo Xu
    • Yong‑Bing Zhao
    • Jin Yu
    • Jian‑Ying Bai
    • En Liu
    • Bo Tang
    • Shi‑Ming Yang
  • View Affiliations

  • Published online on: June 27, 2019     https://doi.org/10.3892/ol.2019.10532
  • Pages: 2560-2567
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The safety and efficacy of endoscopic submucosal dissection (ESD) and radiofrequency ablation for early esophageal cancer (EEC) in cirrhotic patients has not been thoroughly investigated to date. The present study aimed to establish a standard treatment strategy for EEC in cirrhotic patients with esophageal varices. Six cirrhotic patients with early flat‑type EECs (high‑grade intraepithelial neoplasia) on or adjacent to esophageal varices were enrolled. Esophageal varix ligation (EVL) or transjugular intrahepatic portosystemic shunt (TIPS) were used for the initial management of esophageal varices. Follow‑up endoscopy was performed two months following the initial procedure. The mean longitudinal length of the lesions was 4.3 cm (range, 2‑6 cm). The average procedure time was 72.8 min (range, 34‑135 min) and the average longitudinal length of the resected specimens was 45.6 mm (range, 30‑90 mm). One case had a tumor‑positive lateral margin with lymphovascular infiltration. Both complete and curative resection rates were 80% (4/5 lesions). Large intraoperative bleeding was detected in patients undergoing EVL compared with TIPS prior to the ESD procedure. No severe complications or mortality‑associated events, including massive postoperative bleeding, perforation or hepatic failure, were observed. No recurrence and metastasis were observed during the follow‑up period. The current study suggested a novel treatment strategy for EECs complicated by esophageal varices in cirrhosis with good treatment results, no neoplastic progression and an acceptable adverse event profile.
View Figures
View References

Related Articles

Journal Cover

September 2019
Volume 18 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Xu, Z., Zhao, Y., Yu, J., Bai, J., Liu, E., Tang, B., & Yang, S. (2019). Novel endoscopic treatment strategy for early esophageal cancer in cirrhotic patients with esophageal varices. Oncology Letters, 18, 2560-2567. https://doi.org/10.3892/ol.2019.10532
MLA
Xu, Z., Zhao, Y., Yu, J., Bai, J., Liu, E., Tang, B., Yang, S."Novel endoscopic treatment strategy for early esophageal cancer in cirrhotic patients with esophageal varices". Oncology Letters 18.3 (2019): 2560-2567.
Chicago
Xu, Z., Zhao, Y., Yu, J., Bai, J., Liu, E., Tang, B., Yang, S."Novel endoscopic treatment strategy for early esophageal cancer in cirrhotic patients with esophageal varices". Oncology Letters 18, no. 3 (2019): 2560-2567. https://doi.org/10.3892/ol.2019.10532